Answers are grounded in this paper and cite their sources.
Colon cancer (CC) is one of the most recurrent malignancies. Several decades ago, CC had a low incidence. Currently it has become a predominant cancer and contributes in a large amount to the fast rate of morbidity around the world. A steadfast method to identify the disease and improving the prognosis of CC should be developed. Computational drug detection and expansion methods have made an immense contribution to the field of pharmacology. They have accelerated the drug discovery process. Combined efforts of theoretical and computational methods have made possible the invention of drugs against various pathogenic infections. The computational methods have evolved drastically over the past few years to develop therapeutically essential molecules. This review focuses on employing these novel techniques in developing anti-cancer drugs as cancer ranks second in causing higher mortality rates around the globe. Combining these computational drug discovery methods needs to be employed to provide effective therapeutic agents against cancer. Many drugs which have been computationally developed are being used for treatment, and some are under clinical trials. However, there are many target tissues in cancers that are untreated. Hence this review aims at providing information on the novel and innovative methods used in computational drug discovery and development.
No takes yet. Share an insight, caveat, or question.
Patnala et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: